MOESM1 of PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma

Cui, Xiao-bin; Zhang, Shu-mao; Xu, Yue-xun; Dang, Hong-wei; Liu, Chun-xia; Wang, Liang-hai; Yang, Lan; Hu, Jian-ming; Liang, Wei-hua; Jiang, Jin-fang; Li, Na; Li, Yong; Chen, Yun-zhao; Li, Feng

doi:10.6084/m9.figshare.c.3598670_D1.v1

12967_2016_884_MOESM1_ESM.docx (19.74 kB)

MOESM1 of PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma

journal contribution

posted on 2016-05-17, 05:00 authored by Xiao-bin Cui, Shu-mao Zhang, Yue-xun Xu, Hong-wei Dang, Chun-xia Liu, Liang-hai Wang, Lan Yang, Jian-ming Hu, Wei-hua Liang, Jin-fang Jiang, Na Li, Yong Li, Yun-zhao Chen, Feng Li

Additional file 1: Table S1. The high sensitivity, specificity and AUC values of PFN2 in ESCC, HGIN, and LGIN.

Funding

the National Natural Science Foundation of China

History

Usage metrics

Keywords

Profilin 2 ESCC Precursor lesions Prognosis Metastasis

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

MOESM1 of PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma

Funding

the National Natural Science Foundation of China

History

Usage metrics

Categories

Keywords

Licence

Exports